Literature DB >> 6873189

The inhibitory action of FR 34235 (a new Ca2+ entry blocker) as compared to nimodipine and nifedipine on the contractile response to norepinephrine, potassium and 5-hydroxytryptamine in rabbit basilar artery.

T Takagi, N Satake, S Shibata.   

Abstract

In isolated basilar arteries, FR 34235 (FR), a new Ca2+ entry blocker, inhibited the contractile response to potassium, norepinephrine and 5-hydroxytryptamine (5-HT) in a dose-dependent manner. The potency of the inhibitory action of FR was in the following order: potassium greater than 5-HT greater than norepinephrine. Nifedipine had a similar inhibitory action on the responses. Nimodipine had no inhibitory effect on the response to norepinephrine but suppressed the responses to potassium and 5-HT.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6873189     DOI: 10.1016/0014-2999(83)90254-6

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  4 in total

1.  The mode of vasorelaxant action of 2-aminoisoquinoline, 1.3 (2H.4H)-dione, a novel 'intracellular calcium inhibitor'.

Authors:  R K Hester; N Satake; S Shibata; S Ueda; J Yamahara
Journal:  Br J Pharmacol       Date:  1986-02       Impact factor: 8.739

2.  Therapeutic effects of nilvadipine on rat focal cerebral ischemia.

Authors:  Y Li; S Kawamura; N Yasui; M Shirasawa; H Fukasawa
Journal:  Exp Brain Res       Date:  1994       Impact factor: 1.972

3.  Predictors of Unfavorable Outcomes in Patients with Atrial Fibrillation and Concomitant Heart Failure with Different Ejection Fractions: RIF-CHF Register One-Year Follow-Up.

Authors:  Igor Zhirov; Natalia Safronova; Yulia Osmolovskaya; Alina Alshevskaya; Andrey Moskalev; Sergey Tereshchenko
Journal:  Cardiol Res Pract       Date:  2019-05-15       Impact factor: 1.866

4.  Nimodipine-Induced Blood Pressure Changes Can Predict Delayed Cerebral Ischemia.

Authors:  Corinne Fischer; Johannes Goldberg; Sonja Vulcu; Franca Wagner; Daniel Schöni; Nicole Söll; Matthias Hänggi; Jörg Schefold; Christian Fung; Jürgen Beck; Andreas Raabe; Werner J Z'Graggen
Journal:  Front Neurol       Date:  2019-10-31       Impact factor: 4.003

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.